Un artículo de nuestra colaboradora Irene Tarragó

“I have to be very grateful to life, because I have been very lucky with my husband and my children, my little son was diagnosed with epilepsy”

Today, December 9, is our 42nd wedding anniversary. It is said soon. And it doesn’t seem to be that many. Really. After having lived many things together, some good and others not so good, these years have passed so quickly, that it makes me dizzy to think that we are already grandparents.

The freedom of the early years without children. The arrival of the first child, with the novelty, the fears, the ignorance of not knowing what to do… the arrival of the second, with whom we already considered ourselves experts… So many things.

It all started in 1973, when we met. I was 15 years old at the time and still going to school and wearing a uniform. He was already in college. At 17, I was diagnosed with epilepsy and he was still there with me. He has never patronized me, he has always encouraged me to do what I wanted to do, and when I had a seizure, he went out of his way to help me.

I have to be very grateful to life, because I have been very lucky with my husband and my children. When my youngest son was diagnosed with epilepsy, I think it helped me a lot, not only having the disease myself, but also the way my husband treated me so I could treat my son the same way. Without overprotecting him and explaining well what I could and could not do.

May this letter serve as a tribute to my husband who throughout this time has been my friend, my support, my lover, my companion.

I would like to take this opportunity to wish you a Merry Christmas, although this year they will be different, but let’s try to enjoy what they leave us. And I wish you that the next 2021 will treat us all better than this 2020. Much health and care in the holidays.

Leave a Reply

L’usuari que complimenta la informació requerida al present formulari declara estar legitimat per això i es fa responsable exclusiu de la veracitat i integritat de les dades i informació que introdueix, exonerant expressament a MJN NEUROSERVEIS de qualsevol responsabilitat que es pugi generar per aquesta entitat amb ocasió de la informació facilitat a través del present formulari.

Si, accepto

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.